Clinical Trials on Nitric Oxide Pool in Red Blood Cells and Blood Plasma
Total 4037 results
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Leukemia, Plasma CellUnited States
-
University of LiverpoolGenzyme, a Sanofi CompanyUnknownLymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell DyscrasiaUnited Kingdom
-
Baptist Health South FloridaActive, not recruitingMyeloid Malignancy | Lymphoid Leukemia, Acute | Plasma Cell TumorUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingPlasma Cell MyelomaUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
St. Bartholomew's HospitalUnknownLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Italy
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
University of GlasgowCompletedRenal Failure | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fred Hutchinson Cancer CenterCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
Institut Cancerologie de l'OuestTerminatedMultiple Myeloma in RelapseFrance
-
Hellenic Society of HematologyGlaxoSmithKlineNot yet recruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
Omar Nadeem, MDTakedaRecruitingMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Emory UniversityCompleted
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); National...CompletedLymphoma | Plasma Cell MyelomaUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
Thomas Jefferson UniversityCompletedPlasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterTerminatedRecurrent Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Burkitt Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Acute Leukemia in Remission | Acute Undifferentiated Leukemia | Acute Biphenotypic Leukemia and other conditionsUnited States
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Boston VA Research Institute, Inc.Dana-Farber Cancer InstituteCompletedPlasma Cell DisorderUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
Federal Scientific Clinical Centre of Pediatric...Unknown
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMultiple Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Jason ValentCompletedMultiple Myeloma | Kahler Disease | Myelomatosis | Plasma-Cell MyelomaUnited States
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthTerminatedMyeloma-Multiple | Myeloma, Plasma-Cell | MyelomatosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States